The Fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Financial Select Sector Index. Under normal market conditions, the fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index.
- 1 Week
- 1 Month
- 3 Months
- 1 Yr Return
- 5 Yr Return
Top 10 Holdings
|Symbol||Company Name||% Of Assets|
|BRK.B||Berkshire Hathaway Inc ORD||11.91%|
|JPM||JPMorgan Chase & Co ORD||11.37%|
|BAC||Bank of America Corp ORD||7.92%|
|WFC||Wells Fargo & Co ORD||4.70%|
|MS||Morgan Stanley ORD||3.36%|
|C||Citigroup Inc ORD||3.14%|
|GS||Goldman Sachs Group Inc ORD||3.12%|
|BLK||BlackRock Inc ORD||3.02%|
|SCHW||Charles Schwab Corp ORD||2.76%|
|SPGI||S&P Global Inc ORD||2.56%|
|Sponsor||State Street Global Advisors|
|Name||Sel Sector:Finl S SPDR|
|Market Capitalization||229.39 B|
|Total Net Assets||45.34 K|
|Sub Asset Class||Financial Services Funds|
|Number Of Holdings||67|
Master The Market with the Help of Our Financial Experts
Recent Articles from TheStreet
Facebook Owner Meta told by U.K. Antitrust Regulator to Sell Giphy
Facebook parent Meta has been order by the U.K.’s competition watchdog to sell GIF-sharing platform Giphy, which it bought in 2020 for a reported $400 million.
ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug Trial
ImmunoGen said the data would be submitted to the U.S. Food & Drug Administration as party of the agency's' Biologics License Application process in the first quarter of next year.
Lam Research and KLA: 2 Must-Own Chip-Equipment Stocks
Amid the chip shortage, two key equipment stocks fly under the radar: Lam Research and KLA.
Merck Covid-19 Pill to Be Reviewed by FDA Advisory Panel
Merck’s Covid-19 oral antiviral pill will be reviewed by an outside panel of advisors to the FDA on Tuesday, paving the way for potential authorization by year-end.
Moderna Stock Slumps, Regeneron Slides On Omicron Variant Efficacy Warnings
Moderna said its Covid vaccine would likely experience a 'material drop' in efficacy against Omicron, while Regeneron warned its antibody cocktail may also have reduced activity against the new variant.
Moderna Warns on Omicron, Powell, Yellen Face Senate - 5 Things You Must Know
Stocks slump as Omicron concerns resurface; Moderna CEO cautions on vaccine efficacy against new variant; Powell and Yellen to testify before the Senate Banking Committee on CARES Act; FTC orders supply chain probe and cloud adoption software group HashiCorp seeks $13 billion valuation in upcoming Nasdaq IPO.
Cramer's Mad Money Recap 11/29: Omicron, Amazon, Netflix
Jim Cramer reminds investors that the Omicron Covid variant doesn't pose systemic risks to the markets.